Enter the Matrix is a third-person action game developed by Shiny Entertainment and published by Infogrames (under the Atari label) for GameCube, PC, PlayStation 2, and Xbox. It's the first game to be based on the Matrix franchise, and was released on May 14, 2003 to coincide with The Matrix Reloaded. The game's plot acts as a bridge between the first and second films, and follows secondary characters Ghost and Niobe. Despite receiving middling to negative reviews, Enter the Matrix was a financial success.
Why It Sucks
- Very buggy due to being rushed to market (for this instance, for the theatrical release of The Matrix Reloaded).
- Clunky, confusing controls.
- Any tension the action tries to invoke is removed due to the inclusion of regenerating health.
- Idiotic enemy AI.
- Robotic attack animations.
- Inconsistent frame rate.
- Poor shooting mechanics.
- Terrible camera.
- Sluggish driving sections.
- Gameplay often starts and stops a lot, with levels often being separated by cutscenes acting as disguised loading times or opportunities to save your progress.
- The game's plot assumes that you're familiar with the films, which will make the story confusing for those who haven't seen them.
- You are not able to play as Neo which is the main protagonist of the Matrix franchise. The sequel, The Matrix: Path of Neo two years later lets you play as Neo.
- There's little context given for the objectives, leaving you wondering how they tie into the film's plot or what the characters are doing.
- Solid voice acting.
- Ambitious for its time, with entirely original footage shot for the game.
- If you're a huge Matrix fan, the plot will please you.
Enter the Matrix received mixed to negative reviews upon release, with Metacritic scores of 65, 63, 62, and 58 for the Xbox, GameCube, PS2, and PC versions respectively. Despite this, it was the number one selling game of May 2003, with one million copies sold in its first 18 days. It went on to sell 2.5 million units after six weeks, before selling a total of five million copies.